Craig Belcher Email & Phone Number

Australia

London, England, United Kingdom

Vicebio is a UniQuest start-up company. It is developing new protein-based vaccines for life-threatening non-pandemic respiratory viral infectious diseases using UQ’s Molecular Clamp platform technology.

Brisbane, Queensland, Australia

Vaxxas is a UniQuest start-up company commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines. Vaxxas' HD-MAP technology uses a patch with thousands of vaccine-coated microprojections that is applied to the skin for a few seconds to efficiently deliver vaccine to the abundant immune.

Brisbane, Queensland, Australia

Brisbane, Australia

Proud member of UQ's COVID-19 rapid response molecular clamp vaccine deal team from January 2020.Leadership of commercialisation of Life Sciences related intellectual property and expertise at UniQuest to achieve strategic and operational objectives. Life Sciences spans from healthcare, therapeutics, biomedical devices, diagnostics, biological sciences.

Brisbane, Australia

Brisbane, Australia

Brisbane, Australia

Brisbane, Australia

Brisbane, Australia

Lead strategy development and implementation of technology commercialisation at UQ's Australian Institute for Bioengineering and Nanotechnology (AIBN) and Queensland Brain Institute (QBI).Lead and manage small high performance teams on commercialisation projects, deployed on 52 patent families and over 200 discoveries at AIBN, and managing staff directly.

Brisbane, Queensland, Australia

A UniQuest start-up company based on UQ intellectual property with venture capital backing that remains in stealth.

Brisbane, Australia

Dendright is a UniQuest start-up company. It is a clinical-stage biotechnology company developing a tolerizing immunotherapy for the treatment of patients with rheumatoid arthritis (RA). In January 2017, the company extended its R&D Collaboration and Option to License Agreement with US-based Janssen Biotech, Inc. to progress Dendright’s lead drug candidate.

Brisbane, Australia

Nexgen Plants is a UniQuest start-up company. It is commercializing a novel platform technology that enables virus resistant plant varieties to be developed for major food, fibre, energy and ornamental crops used around the world.

Brisbane, Australia

AquaHydrex is a UniQuest start-up company. It is developing a unique electro-chemical platform technology capable of transforming significant industrial gas and energy market segments. It was established by UniQuest in 2012 when it was commercialising for the University of Wollongong and attracted investment from Chicago based True North Venture Partners..

Brisbane, Australia

Tenasitech is a UniQuest start-up company commercialising scratch-resistant plastic nanoparticle additives. November 2020 acquired by RTP Company to add new products to its portfolio, initially targeting acrylic, polyamide and polyester resin materials. RTP is a US-based leading global compounder of custom engineered thermoplastics. Founding Board member.

Directly involved in therapeutic antibody deal-making with Genzyme (antibody library license), Xerion Pharmaceuticals (allergy target validation) and Incyte (access to Incyte’s LifeSeq® database with options to license antibody target IPR). Post-deal alliance manager for therapeutic antibody deals with Chugai Pharmaceuticals (a Japanese subsidiary of.

Mba

Awarded 2009 Dean's Honour Roll - recognises outstanding academic excellence across the entirety of MBA program. The Economist global.

Gaicd

Graduate

Phd, Molecular Biology, Diagnostics

Bappsci, Biotechnology